Company news
Hydrix Limited (ASX:HYD) news
Hydrix Limited news releases on 6ix. Latest, Sep 17, 2026: Hydrix Medical contract with National Heart Centre Singapore
Press releases & updates
Hydrix Medical contract with National Heart Centre Singapore
September 16, 2026
Hydrix Advancing Strategic Defence Activities
August 30, 2026
Remedy Robotics awards HYD A$3.4M Surgical Robotics Contract
July 19, 2026
Reinstatement of security class- HYDOC
June 18, 2026
Results of Retail Entitlement Offer
June 10, 2026
Security Class Suspension from Quotation - HYDOC
June 8, 2026
Hydrix positioned for Defence tech expansion
May 19, 2026
Accelerated renounceable entitlement offer to raise $8.18m
May 18, 2026
Prospectus - Entitlement Offer
May 17, 2026
NIOA contracts Hydrix to advance counter-drone technology
May 14, 2026
Trading Halt-Accelerated Offer
May 13, 2026
Trading Update and Growth Outlook
February 26, 2026
Half Yearly Report and Accounts
February 26, 2026
Amended Appendix 4C
February 1, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 30, 2026
SynCardia and Hydrix Enter into Development Collaboration to Advance the Emperor, SynCardia’s Next Generation Total Artificial Heart
January 12, 2026
$2.5m contract to develop SynCardia's next generation TAH
January 7, 2026
Reinstatement to official quotation - 13 October 2025
October 10, 2025
Suspension from Quotation
September 30, 2025
Timing of lodgement of FY25 accounts
September 30, 2025
Response to ASX Price Query
September 23, 2025
Preliminary Final Report
August 29, 2025
Mid-year Market Update
February 27, 2025
Appendix 4D and Half Yearly Report
February 27, 2025
Hydrix signs key international $2.8m contract
January 22, 2025
Preliminary Final Report and Market Update
August 30, 2024
Appendix 4E
August 30, 2024
Hydrix Ventures reduces Avertix Medical to current valuation
August 12, 2024
Quarterly Activities Report/Appendix 4C and Trading Update
July 30, 2024
Hydrix signs $2.3m contract
May 26, 2024
Half Year Results and Trading Update
February 28, 2024
Update on Avertix Medical Business Combination
October 5, 2023
Pause in trading
October 4, 2023
FY2023 Letter from Executive Chairman
August 28, 2023
FY2023 Results Announcement
August 28, 2023
FY2023 Appendix 4E and Financial Report
August 28, 2023
Quarterly Activities/App 4C & Convertible Note Capital Raise
July 31, 2023
Hydrix Medical appoints Guardian sub-distributor in Malaysia
May 17, 2023
Hydrix signs distribution agreement with Implicity
May 16, 2023
Hydrix Ventures - Avertix Medical NASDAQ Listing Update
May 15, 2023
HYD: Hydrix signs agreement to sell EIQ's EchoSolv platform
May 1, 2023
Hydrix signs $1.5m revolving loan facility
April 18, 2023
Hydrix signs $1.48 million contract with Cyban Pty Ltd
February 27, 2023
Appendix 4D and Half-Yearly Report
February 27, 2023
Withdrawal / future resubmission of Guardian TGA application
February 27, 2023
TGA response to Guardian application
February 14, 2023
Trading halt
February 12, 2023
Prospectus for Loyalty Options Offer
October 27, 2022
Hydrix Loyalty Options Offer
October 27, 2022
Quarterly Activities Report and Appendix 4C
October 27, 2022